Inclusion Criteria:  Unresectable HCC patients were diagnosed by a surgeon and/or radiologist and oncologist according to the international guidelines for the management of HCC or by pathology Patients who received SBRT plus TACE have tumor regression, and surgical experts assess that R0 resection could be achieved CP-A or B classification; Eastern Cooperative Oncology Group (ECOG) score 0-1; Platelet count≥50 × 109/L, white blood count≥1.5 × 109/L; ICG R15≤10%; Normal effective liver volume >30%; patients infected with hepatitis B virus who are treated with adefovir or entecavir; patients infected with hepatitis C virus whose HCV DNA are negative.  Exclusion Criteria:  -the patients receive other treatments (such as targeted treatment, immune checkpoint inhibitors,etc) after CK-SBRT plus TACE.